Literature DB >> 19885229

Predicted blood glucose from insulin administration based on values from miscoded glucose meters.

Charles H Raine1, Scott Pardo, Joan Lee Parkes.   

Abstract

OBJECTIVES: The proper use of many types of self-monitored blood glucose (SMBG) meters requires calibration to match strip code. Studies have demonstrated the occurrence and impact on insulin dose of coding errors with SMBG meters. This paper reflects additional analyses performed with data from Raine et al. (JDST, 2:205-210, 2007). It attempts to relate potential insulin dose errors to possible adverse blood glucose outcomes when glucose meters are miscoded.
METHODS: Five sets of glucose meters were used. Two sets of meters were autocoded and therefore could not be miscoded, and three sets required manual coding. Two of each set of manually coded meters were deliberately miscoded, and one from each set was properly coded. Subjects (n = 116) had finger stick blood glucose obtained at fasting, as well as at 1 and 2 hours after a fixed meal (Boost((R)); Novartis Medical Nutrition U.S., Basel, Switzerland). Deviations of meter blood glucose results from the reference method (YSI) were used to predict insulin dose errors and resultant blood glucose outcomes based on these deviations.
RESULTS: Using insulin sensitivity data, it was determined that, given an actual blood glucose of 150-400 mg/dl, an error greater than +40 mg/dl would be required to calculate an insulin dose sufficient to produce a blood glucose of less than 70 mg/dl. Conversely, an error less than or equal to -70 mg/dl would be required to derive an insulin dose insufficient to correct an elevated blood glucose to less than 180 mg/dl. For miscoded meters, the estimated probability to produce a blood glucose reduction to less than or equal to 70 mg/dl was 10.40%. The corresponding probabilities for autocoded and correctly coded manual meters were 2.52% (p < 0.0001) and 1.46% (p < 0.0001), respectively. Furthermore, the errors from miscoded meters were large enough to produce a calculated blood glucose outcome less than or equal to 50 mg/dl in 42 of 833 instances. Autocoded meters produced zero (0) outcomes less than or equal to 50 mg/dl out of 279 instances, and correctly coded manual meters produced 1 of 416.
CONCLUSIONS: Improperly coded blood glucose meters present the potential for insulin dose errors and resultant clinically significant hypoglycemia or hyperglycemia. Patients should be instructed and periodically reinstructed in the proper use of blood glucose meters, particularly for meters that require coding.

Entities:  

Keywords:  autocoded meter; blood glucose meter; manually coded meters; miscoded meter; user error

Year:  2008        PMID: 19885229      PMCID: PMC2769763          DOI: 10.1177/193229680800200404

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  12 in total

1.  Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist.

Authors:  Gunn B B Kristensen; Kari Nerhus; Geir Thue; Sverre Sandberg
Journal:  Clin Chem       Date:  2004-06       Impact factor: 8.327

2.  Time synching or time sinking?

Authors:  Daniel J Crowe; David C Klonoff
Journal:  Diabetes Technol Ther       Date:  2005-10       Impact factor: 6.118

Review 3.  Continuous glucose monitoring: roadmap for 21st century diabetes therapy.

Authors:  David C Klonoff
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

5.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 6.  The dawn phenomenon revisited: implications for diabetes therapy.

Authors:  Mary F Carroll; David S Schade
Journal:  Endocr Pract       Date:  2005 Jan-Feb       Impact factor: 3.443

Review 7.  Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.

Authors:  Bruce W Bode; Susan S Braithwaite; R Dennis Steed; Paul C Davidson
Journal:  Endocr Pract       Date:  2004 Mar-Apr       Impact factor: 3.443

8.  Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters.

Authors:  Charles H Raine; Linda E Schrock; Steven V Edelman; Sunder Raj D Mudaliar; Weiping Zhong; Lois J Proud; Joan Lee Parkes
Journal:  J Diabetes Sci Technol       Date:  2007-03

9.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

10.  Medication use leading to emergency department visits for adverse drug events in older adults.

Authors:  Daniel S Budnitz; Nadine Shehab; Scott R Kegler; Chesley L Richards
Journal:  Ann Intern Med       Date:  2007-12-04       Impact factor: 25.391

View more
  9 in total

1.  Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study.

Authors:  Marc D Breton; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

2.  An analysis: to code or not to code-that is the question.

Authors:  Barry H Ginsberg
Journal:  J Diabetes Sci Technol       Date:  2008-09

Review 3.  Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes.

Authors:  Alison F Smith; Bethany Shinkins; Peter S Hall; Claire T Hulme; Mike P Messenger
Journal:  Clin Chem       Date:  2019-08-23       Impact factor: 8.327

4.  Integrated self-monitoring of blood glucose system: handling step analysis.

Authors:  Guido Freckmann; Christina Schmid; Katharina Ruhland; Annette Baumstark; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

5.  Bolus Insulin Dose Error Distributions Based on Results From Two Clinical Trials Comparing Blood Glucose Monitoring Systems.

Authors:  Scott Pardo; Nancy Dunne; David A Simmons
Journal:  J Diabetes Sci Technol       Date:  2017-06-12

6.  Performance of the CONTOUR® TS Blood Glucose Monitoring System.

Authors:  Joy Frank; Jane F Wallace; Scott Pardo; Joan Lee Parkes
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

7.  The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

8.  Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.

Authors:  Enrique Campos-Náñez; Kurt Fortwaengler; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2017-06-01

9.  How Should Blood Glucose Meter System Analytical Performance Be Assessed?

Authors:  David A Simmons
Journal:  J Diabetes Sci Technol       Date:  2015-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.